Company intelligence / Profile preview

Huanghai

Qingdao, Shandong, China

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Qingdao Huanghai Pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the development and production of sustained-release drug delivery systems. Founded in 1959 and headquartered in Qingdao, the company has established itself as a leader in the domestic market for cardiovascular and endocrine treatments. Its flagship products include Yitong (Nifedipine Sustained-release Tablets) and various formulations for diabetes and pain management. The company maintains extensive GMP-certified manufacturing facilities and focuses on high-quality generic medications and improved formulations. Huanghai Pharmaceutical continues to expand its portfolio through internal R&D and strategic industrial upgrades.

Therapeutic areas: EndocrinologyRheumatologyCardiovascularNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Huanghai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huanghai.

Explore the full profile